Team:Johns Hopkins/Team/Advisors

From 2011.igem.org

(Difference between revisions)
Line 26: Line 26:
         <ul>
         <ul>
<li><a href="#" onclick="$('#boxcontent').html('<b>Dr. Jef Boeke</b> is a professor of Molecular Biology and Genetics, and the founding director of High Throughput Biology Center at the Johns Hopkins University School of Medicine.<br/>(<a href=\'http://www.bs.jhmi.edu/MBG/boekelab/\'>Homepage</a>)');return false;"><img src="https://static.igem.org/mediawiki/2011/6/6d/Profile_Jef.jpg"/><br/>Jef Boeke</a><br/></li>
<li><a href="#" onclick="$('#boxcontent').html('<b>Dr. Jef Boeke</b> is a professor of Molecular Biology and Genetics, and the founding director of High Throughput Biology Center at the Johns Hopkins University School of Medicine.<br/>(<a href=\'http://www.bs.jhmi.edu/MBG/boekelab/\'>Homepage</a>)');return false;"><img src="https://static.igem.org/mediawiki/2011/6/6d/Profile_Jef.jpg"/><br/>Jef Boeke</a><br/></li>
-
<li><a href="#" onclick="$('#boxcontent').html('<b>Dr. Takanari Inoue</b> received his graduate education at the University of Tokyo, where he developed a novel chemical-biological technique. Takanari then moved to the Bio-X program at Stanford University as a Quantitative Chemical Biology Fellow. His work at Stanford focused on the creation of other novel synthetic biological techniques that could rapidly – and inducibly – manipulate activity of a variety of intracellular signaling molecules. Currently, the Inoue laboratory at Johns Hopkins is investigating positive-feedback mechanisms underlying the initiation of neutrophil chemotaxis (known as symmetry breaking), as well as spatio-temporally compartmentalized signaling of Ras and membrane lipids such as phosphoinositides. Ultimately, Takanari will generate completely orthogonal machinery in cells to achieve existing, as well as novel, cellular functions.');return false;"><img src="https://static.igem.org/mediawiki/2011/8/83/Profile_Inoue.jpg"/>Takanari Inoue</a><br/></li>
+
<li><a href="#" onclick="$('#boxcontent').html('<b>Dr. Takanari Inoue</b> received his graduate education at the University of Tokyo, where he developed a novel chemical-biological technique. Takanari then moved to the Bio-X program at Stanford University as a Quantitative Chemical Biology Fellow. His work at Stanford focused on the creation of other novel synthetic biological techniques that could rapidly – and inducibly – manipulate activity of a variety of intracellular signaling molecules. Currently, the Inoue laboratory at Johns Hopkins is investigating positive-feedback mechanisms underlying the initiation of neutrophil chemotaxis (known as symmetry breaking), as well as spatio-temporally compartmentalized signaling of Ras and membrane lipids such as phosphoinositides. Ultimately, Takanari will generate completely orthogonal machinery in cells to achieve existing, as well as novel, cellular functions.<br/>(<a href=\'http://esgweb1.nts.jhu.edu/cellbio/dept/InoueProfile.html\'>Homepage</a>)');return false;"><img src="https://static.igem.org/mediawiki/2011/8/83/Profile_Inoue.jpg"/>Takanari Inoue</a><br/></li>
         </ul>
         </ul>
     </li>
     </li>

Revision as of 20:07, 18 August 2011

VitaYeast - Johns Hopkins University, iGEM 2011


Click on an advisor's picture to get to know him better.